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Background. This meta-analysis seeks to quantify the prospective association between neuroticism and the common
mental disorders (CMDs, including anxiety, depression, and substance abuse) as well as thought disorders (psych-
osis/schizophrenia) and non-speciﬁc mental distress. Data on the degree of confounding of the prospective association
of neuroticism by baseline symptoms and psychiatric history, and the rate of decay of neuroticism’s effect over
time, can inform theories about the structure of psychopathology and role of neuroticism, in particular the vulnerability
theory.
Method. This meta-analysis included 59 longitudinal/prospective studies with 443 313 participants.
Results. The results showed large unadjusted prospective associations between neuroticism and symptoms/diagnosis of
anxiety, depression, and non-speciﬁc mental distress (d = 0.50–0.70). Adjustment for baseline symptoms and psychiatric
history reduced the associations by half (d = 0.10–0.40). Unadjusted prospective associations for substance abuse and
thought disorders/symptoms were considerably weaker (d = 0.03–0.20), but were not attenuated by adjustment for base-
line problems. Unadjusted prospective associations were four times larger over short (<4 year) than long (54 years) fol-
low-up intervals, suggesting a substantial decay of the association with increasing time intervals. Adjusted effects,
however, were only slightly larger over short v. long time intervals. This indicates that confounding by baseline symp-
toms and psychiatric history masks the long-term stability of the neuroticism vulnerability effect.
Conclusion. High neuroticism indexes a risk constellation that exists prior to the development and onset of any CMD.
The adjusted prospective neuroticism effect remains robust and hardly decays with time. Our results underscore the
need to focus on the mechanisms underlying this prospective association.
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Neuroticism
Neuroticism is one of the broad traits at the apex of
personality taxonomy. The term neuroticism has its
roots in Freudian theory, but the modern concept of
neuroticism has been introduced by Hans Eysenck
and contemporaries, who used a range of methods
from personality psychology, including psychophysio-
logical and lexical studies (Dumont, 2010).
Currently, consensus has developed that, at its core,
neuroticism is the propensity to experience negative
emotions (Clark & Watson, 1999; John et al. 2008;
Matthews et al. 2009; Widiger, 2009), including anxiety,
fear, sadness, anger, guilt, disgust, irritability, loneli-
ness, worry, self-consciousness, dissatisfaction, hostil-
ity, embarrassment, reduced self-conﬁdence, and
feelings of vulnerability, in reaction to various types
of stress, and tend to select themselves into situations
that foster negative affect (Lüdtke et al. 2009; Specht
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et al. 2011; Jeronimus et al. 2014; Riese et al. 2014).
Importantly, the total ‘excess economic costs’ asso-
ciated with the 25% highest neuroticism scores in the
Netherlands have been estimated at twice that of all
common mental disorders (CMDs) combined, and
about two-thirds of the excess costs of somatic pro-
blems (Cuijpers et al. 2010).
Association with psychopathology
High neuroticism scores are strongly associated with
psychopathology, in particular the CMDs, including
anxiety, mood, and substance use disorders (Ormel
et al. 2001; Saulsman & Page, 2004; Malouff et al. 2005;
Ruiz et al. 2008; Kotov et al. 2010). An inﬂuential
meta-analysis quantiﬁed neuroticism’s cross-sectional
association with CMDs, ranging in magnitude from
Cohen’s d of 0.50 for substance disorders, to 2.00 for
some anxiety and mood disorders (Kotov et al. 2010).
Neuroticism is also prospectively associated with
CMDs, although the associations are typically smaller
(d = 0.20–0.60, see Lahey, 2009; Kotov et al. 2010; Ormel
et al. 2013; Hakulinen et al. 2015a, b; Vall et al. 2015).
Neuroticism’s prospective association with CMDs
has fueled the assumption that neuroticism is an inde-
pendent etiologically informative risk factor. This vul-
nerability model postulates that neuroticism sets in
motion processes that lead to developing CMDs.
However, ﬁve other models seek to explain the associ-
ation, including the spectrum model (extreme neuroti-
cism is called disorder), common cause model (distinct
constructs that share determinants), state and scarmod-
els (CMD episodes change neuroticism levels tempor-
arily/permanently). Recently we reviewed the validity
of these models provided the available literature on
confounding of the prospective association by baseline
symptoms and psychiatric history, operational over-
lap, stability and change, determinants, and treatment
effects (Ormel et al. 2013). We concluded that none of
the models can account for (virtually) all ﬁndings,
viz. the state and scar model cannot explain the pro-
spective association, the spectrum model has some
relevance, especially for internalizing disorders, but
common causes are important as well.
Some of the reviewed ﬁndings, such as the prospect-
ive associations and interactions of neuroticism with
stress (Kendler et al. 2003; Lüdtke et al. 2009; Specht
et al. 2011; Jeronimus et al. 2014; Riese et al. 2014), are
especially consistent with the vulnerability model.
Also the higher stability of neuroticism over time
than internalizing symptoms supports the vulnerabil-
ity model (Ormel et al. 2013; Nivard et al. 2015a, b).
However, ﬁrm conclusions regarding the vulnerability
model were hampered by limited data on the degree of
confounding of the prospective association by baseline
symptoms and psychiatric history, and the rate of
decay of neuroticism’s effect over time. The present
meta-analysis aims to ameliorate this lack of insight
as much as possible, provided the available data, and
included studies of the prospective association be-
tween neuroticism and CMDs, to compare the strength
of the prospective associations by differencing follow-
up period, with and without adjustment for baseline
problems. Additionally, the present meta-analytic
study included some non-CMDs as well, such as
thought disorders.
Thought disorders
The link between neuroticism and CMDs received
most attention. Nonetheless, neuroticism also appears
to be related to a set of prominent cognitive-perceptual
and affect regulation problems, grouped in what has
been called the schizo-affective-psychosis continuum
of ‘thought disorders’ (Markon, 2010; Kotov et al.
2011; Keyes et al. 2013). Thought disorders are marked
by idiosyncratic perceptions (or ‘positive symptoms’)
that are quite common in the general population
(Hanssen et al. 2005; Nuevo et al. 2012), including devi-
ant beliefs (‘delusions’), feelings, and perceptions (‘hal-
lucinations’), which can ﬂair up temporary (i.e.
‘schizotypy’), or decompensate into a full-blown dis-
order (van Os et al. 2009; Keyes et al. 2013; including
schizophrenia, psychotic disorders, obsessive compul-
sive disorders, and schizotypical personality disor-
ders). Thought disorders are also marked by social
deﬁcits (‘negative symptoms’), including poor social
skills, social anxiety, withdrawal, social disinterests
(anhedonia), and impaired perspective-taking ability
(Brown et al. 2008; Pijnenborg et al. 2011). Recently it
has been argued that thought disorders represent the
most general expression of psychopathology, and
may account for the overlap between internalizing
and externalizing symptoms/disorders (Lahey et al.
2011; Caspi et al. 2013; Kotov et al. 2015; Laceulle
et al. 2014). Although thought disorders are less preva-
lent than the CMDs, they represent an important
domain of psychopathology, and therefore it is
important to investigate the prospective association
between neuroticism and thought disorders.
The present study
The current study seeks to quantify the prospective asso-
ciationbetweenneuroticismon the onehandandCMDs,
thought disorders, and non-speciﬁc mental distress on
the other. Additionally, we seek to quantify the extent
of confounding of the prospective association between
neuroticism and CMDs by baseline symptoms and/or
psychiatric history. To do so, we were particularly
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interested in studies that assessed psychopathology at
baseline (i.e. concomitant with neuroticism), and
reported on adjusted prospective associations. For ex-
ample, prospective associations adjusted for baseline
symptoms, or studies that excluded subjects with a
history of and/or current psychopathology. Finally, the
vulnerability model of psychopathology assumes lim-
ited decay of the association with increasing time be-
tween baseline assessment of neuroticism and outcome
assessment. Therefore the temporal persistence of the
prospective association between neuroticism and psy-
chopathology was examined as well. Altogether, all
studies that report on univariate and multivariate mod-
els for baseline neuroticism prospectively predicting
psychopathology were identiﬁed (with and without ad-
justment for baseline problems and psychiatric history),
and the reported coefﬁcients were transformed, pooled,
and compared in the current meta-analysis.
Materials and method
Search strategy
The Web of Knowledge was searched on 1 November
2015 with three search strings; (a) neuroticism, trait
anxiety, negative affectivity or emotional stability;
(b) mental disorder, internalizing disorder, externalizing
disorder, psychopathology, mental health/illness, anx-
iety, depression, substance abuse, substance depend-
ence, alcohol dependence, drug dependence, psychosis,
psychoses, psychotic, psychotic disorder, schizophrenia,
schizoaffective disorder, delusional disorder, paranoid
psychosis, schizophreniform disorder, or dissociative
disorder, and (c) longitudinal, prospective or follow-up.
We also searched the references of the included studies
for additional studies to overcome search string limita-
tion. From the manuscripts we coded information on
sample size, history of psychopathology, comorbidities,
the personality measure, and psychopathology measure
(e.g. continuous or categorical/binary Sx or Dx). The
application of the search strategy is depicted in a
ﬂowchart given as Fig. 1 and all included studies can be
found in Table 1.
Study selection criteria
Studies were included that comprised (a) an adult sam-
ple that was aged at least 18 years at follow-up (T2)
from (b) the general population with (c) at least 200
participants that assessed (d) neuroticism at baseline
(T1) and (e) psychopathology [symptoms (Sx) or
diagnosis (Dx)] at T2, and (f) the follow-up interval
(T1–T2) had to be at least 1 year. This means that
twin studies were included but patient groups (psychi-
atric/somatic) and prisoners were excluded. The
included measures of psychopathology had to ﬁt the
ﬁve selected categories of interest: (a) Anxiety disorders,
including post-traumatic sreess disorder (PTSD), panic
disorder, generalized anxiety disorder (GAD), and
phobic disorders; (b) Depression, including suicide
and dysthymia; (c) Substance abuse, such as illicit
drugs, alcohol and tobacco; (d) Thought disorders, in-
cluding psychosis and schizophrenia, and (e) non-
speciﬁc mental distress.
Non-speciﬁc mental distress
Anumber of studies examined symptoms and signs that
either did notmeet diagnostic criteria (NOS or subthres-
hold) orwere not assessed in away that linked them to a
speciﬁc disorder (e.g. a total of all symptoms).Wecumu-
lated these data under a separate category of non-
speciﬁc mental distress, which is conceptually close to
high neuroticism, but importantly, assessed on a differ-
ent time-frame (‘state’ v. ‘trait’, see Ormel et al. 2013,
2014).Non-speciﬁcmental distress refers to a continuum
of disturbing or unpleasant emotional/mental states that
interfere with one’s ability to cope with daily living.
Because this cluster may inform hypotheses about the
personality–psychopathology association it has been
included in this meta-analysis.
Conversion of outcomes
The heterogeneity of the outcome measures only
allowed us to conduct a bare-bones meta-analysis in
which effect sizes were converted into standardized
mean difference d (Hunter & Schmidt, 2004).
Conversion formulas were attained from the literature
(Rosenthal, 1994; Sanchez-Meca et al. 2003; Peterson &
Brown, 2005; Borenstein et al. 2009), and can be found
in Supplementary Table S1. Odds ratios (ORs) that
indicated the effect on outcome per scale unit of the
raw metric of the predictor were converted to reﬂect
ORs on standardized metric (i.e. per standard devi-
ation of the predictor). In addition, ORs for neuroti-
cism scales that indicated low-neuroticism with high
scores were mirrored via 1/ORs to enable comparison.
Four included studies reporting hazard ratios were
excluded from our meta-analytic estimates, as they
cannot be converted to ORs exactly. The relationship
index r depicts measures of association or variance
accounted for effect size. We classiﬁed correlations (r)
and betas as small if between 0.10 and 0.20, moderate
between 0.20 and 0.30, and large if >0.30, based on the
effect sizes commonly found in social psychology
(Richard et al. 2003; Peterson & Brown, 2005).
Summary statistics
Summary statistics were calculated for each cluster of
disorders separately (anxiety, depression, substance
Association between neuroticism and mental disorders 2885
https://doi.org/10.1017/S0033291716001653
Downloaded from https:/www.cambridge.org/core. University of Groningen, on 14 Feb 2017 at 12:32:10, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
abuse, thought disorders, non-speciﬁc mental distress).
If the study reported multiple outcome measures with-
in a given category on a given sample (e.g. multiple de-
pression scales), effect sizes were averaged to ensure
that assumption of independence of observations is
met, as recommended by Hunter & Schmidt (2004).
Summary statistics were sample-size weighted to ob-
tain most accurate estimates. If a study reported data
on multiple follow-ups, the longest follow-up interval
between personality assessment and psychopathology
assessment was chosen. Three detailed selection rules
were applied for the summary statistics. (a) If manu-
scripts reported several effect-sizes for the same associ-
ation (outcome) in the same sample but for different
levels of adjustment the best-adjusted effect size was
included in the adjusted summary statistic (e.g. exclu-
sion of subjects with a history of psychopathology and
adjustment for baseline Sx). (b) If manuscripts reported
several effect sizes for the same association (outcome)
in the same sample, but for dichotomous and continu-
ous measures, the latter was chosen for analyses. (c) In
addition, analyses were stratiﬁed by follow-up inter-
val. To do so, we divided our estimates over a short-
and long-term follow-up interval, based on the median
split; which is an arbitrary decision. This median split
was based on the overall median study duration
(to increase comparability), but was also calculated
for dichotomous and continuous measures separately.
In sum, all effect sizes that could be converted into
Cohen’s d values were used to estimate the summary
statistics reported in Tables 2–4.
Results
Study selection
A total of 5086 records were screened for inclusion. The
selection on title and abstracts reduced the number to
631 papers, which were further scrutinized with the
study selection criteria, as outlined above. Eventually
63 studies were included, while the estimates in 59
studies could be converted to Cohen’s d. This yielded
111 effect estimates. Our meta-analyses were based
on 443 313 participants over almost 5 million follow-up
years. At baseline the participants ranged in age from
14 to 104 years.
Some studies were performed in the eligible popula-
tion and administered all variables of interest, but
reported on other variables as predictor and/or out-
come (e.g. Bak et al. 2005). Other studies adjusted the
prospective association between neuroticism and out-
come for the other four broad personality domains
Fig. 1. Flow chart of the search strategy of studies on the prospective association between neuroticism and common mental
disorders, thought disorders and, non-speciﬁc mental distress. The sum of all disorders exceeds 63 because some studies
assessed multiple outcomes. The percentages (%) indicate the proportion for which this requirement was not met.
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Table 1. Prospective population-based studies (k = 63) linking neuroticism (N) to psychopathology [symptoms (Sx) or diagnoses (Dx)]
First-named
author
Pub.
year Sample Size
C
(%)
Age (range and
mean (S.D.) at T1) T1/T2 (yr) Outcome variable N scale Cat. Comp.
Effect sizes
study outcome d’s
Adjustment for baseline (T1)
psychopathology
Anxiety (including PTSD, panic disorder, GAD, and phobic disorders)
Newton-Howes 2015 Pop. 903 Nsc 14 10 (10) Dx Since previous
assessment
EPI 30 S.D. OR = 1.56a 0.12 No
OR = 1.25a 0.06 Yes e.g. childhood mental
health problems, sexual/
physical abuse
Aldinger 2014 Pop. 266 56 M = 25 (2.3) 9 Dx Past 9 yr NEO-FFI 48 2 v. 1 (8) OR = 6.84c
β = 1.92c
0.51
2.34
No
β = 0.17a 0.44 Yes Adj. for internalizing Sx
at T1
Kendler 2011 Twins 2395 100 29 (8) 8 (1) Sx Past mo. EPQ-R 48 Cont. SPRC = 0.24d 0.60 No
Calkins 2009 Pop. 643 100 36–45, M = 40 3 Dx Past 3 yr NEO-FFI 48 Cont. HR = 1.08a^S.D. Yes Ss LT depression at T1
excl.
Dx Past 3 yr Cont. HR = 1.02ns^S.D. Yes Ss LT depression at T1
excl. adj. for T1 AnxSx
Vink 2009 CC 1712 49 55–85 9 Dx Past mo. DPQ 50 Cont.^S.D. OR = 1.46a 0.23 Yes Ss with Dx depression/
anxiety at T1 were excl.
Dx Past mo. Cont.^S.D. OR = 1.26ns 0.14 Yes Ss with Dx depression/
anxiety at T1 were excl.,
and results adj. for Sx
depression/anxiety at T1
Cox 2008 Pop. 585 49 M = 43 (17) 1 Sx Past wk NEO-FFI 20 Cont. r = 0.56ng 1.35 No
Sx Past wk Cont. β = 0.23a 0.57 Yes Adj. for Sx anxiety at T1
Beard 2007 Pop. 968 57 18–85 1 Dx Any, past yr EPQ 24 v. Ctr. OR = 1.22a 0.12 Yes Ss with mental Dx
(ICD-10 criteria) at T1
excl.
Dx GAD, past yr 24 v. Ctr. OR = 1.33d 0.17 Yes Ss with mental Dx
(ICD-10 criteria) at T1
excl.
Mofﬁtt 2007 Pop. 945 48 M = 18 14 Dx GAD,51 mo. MPQ NE, Z v. Ctr. t = 5.29a 0.66 Yes Adj. for childhoodmental
disorders Dx
Schmidt 2007 Pop. 405 61 M = 19 (4) 2 Dx Past 2 yr STPI-Trait 60 Cont. OR = 2.20 0.48 Yes Ss with psychiatric Sx/Dx
past 12 mo. excl. at T1
Dx Panic Dx Cont. OR = 2.00 0.42 Yes Ss with psychiatric Sx/Dx
past 12 mo. excl. at T1
Dx Panic attack Cont. OR = 2.20 0.48 Yes Ss with psychiatric Sx/Dx
past 12 mo. excl. at T1
A
ssociation
betw
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neuroticism
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Table 1 (cont.)
First-named
author
Pub.
year Sample Size
C
(%)
Age (range and
mean (S.D.) at T1) T1/T2 (yr) Outcome variable N scale Cat. Comp.
Effect sizes
study outcome d’s
Adjustment for baseline (T1)
psychopathology
Parslow 2006 Pop. 2085 53 20–24 4 Sx PTSD, past wk EPQ-R 2 (3) v. Ctr. M (S.D.) 0.55 No
Sx PTSD, past wk 24 Cont. IRR^S.D. = 1.18 0.11 Yes Adj. for T1 depression
and anxiety Sx.
De Graaf 2004 Pop. 2869 53 M = 42 (12) 3 Dx Past 3 yr GNS 14 v. Ctr. OR = 1.12a 0.07 Yes Ss with history of mental
Dx excl. at T1
Goodwin 2003 Pop./CC 961 50 M = 14 7 Dx GAD, past 3 yr EPI 2 (3) 2 v. 1 Rates (%)ng 0.86 No
Dx Panic, past 3 yr 2 v. 1 Rates (%)ng 1.57 No
Dx Soc.Ph., past 3 yr 2 v. 1 Rates (%)ng 0.76 No
De Graaf 2002 Pop. 5618 50 18–64 1 Dx Past yr GNS 2 (4) 2 v.1 OR = 2.05d 0.44 No
Dx Past yr 2 v. 1 OR = 1.23ns 0.13 Yes Adj. for Sx depression and
substance abuse at T1
Hagglin 2001 Pop. 310 100 38–54 24 Sx High dental fear EPI-B 48 2 v. 1 X2 = 9.2d 0.37 No
Wetherell 2001 Twins 1031 57 29–95, M = 61 (13) 6 Sx Past wk STPI-Trait 50 Cont. r = 0.58ng 1.42 No
De Beurs 2000 Pop. 1602 84 55–85 3 Sx Past mo. DPI 2 (5) 2 v. 1 OR = 2.8d 0.62 Yes Ss with anxiety excl. at T1
Krueger 1999 Pop./CC 961 50 M = 18 3 Dx Past yr MPQ NE Z Cont. OR = 1.63d 0.30 Yes Adj. for Anxiety Sx at T1
Sx Past yr Cont. β = 0.18d 0.46 Yes Adj. for Anxiety Sx at T1
Gershuny 1998 Pop. 466 53 M = 18 (1) 3 Sx Past wk EPQ 23 Cont. r = 0.30a 0.63 No
Sx Past wk Cont. β = 0.067ns 0.23 Yes Adj. for Sx anxiety at T1.
Caspi 1996 CC 1037 48 M = 3 18 Sx Past yr BRIC 2 (2) v. Ctr. M(S.D.)ns 0.18 No
Krueger 1996 Pop. 897 48 M = 18 3 Sx Past yr MPQ NE 49 Cont. r = 0.27c 0.56 No
Levenson 1988 Pop. 1324 0 40–98 10 Sx Any, past 3 mo. EPI 9 Cont. r = 0.42a 0.93 No
Sx Phobic, past 3 mo. 9 Cont. r = 0.26a 0.54 No
Depression (including suicide and dysthymia)
Hakulinen 2015b Pop. 56 735 54.7 15–104, M = 49.0 5 Sx Past 5 yr (n=9),
various
15 Cont. β = 0.12a 0.34 No Adj. for extraversion,
conscientiousness,
openness and
agreeableness (!)
Newton-Howes 2015 Pop. 903 14 10 (10) Dx Since previous
assessment
EPI 30 S.D. OR = 1.54a 0.11 No
OR = 1.39a 0.09 Yes Adj. for childhood mental
health problems and
sexual/physical abuse,
among others
Aldinger 2014 Pop. 266 56 M = 25 (2.3) 9 Dx Past 9 yr NEO-FFI 12 2 v. 1 (8) OR = 14.00a
β = 2.64a
0.69
2.16
No
No
β = 0.08d 0.26 Yes Adj. for internalizing Sx
at T1
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Kendler 2011 Twins 2395 100 29 (8) 8 (1) Sx Past mo. EPQ-R 12 Cont. SPRC = 0.24d 0.60 No
Inoue 2010 Pop. 15 256 0 18–67 5 Dx Past 5 yr EPQ-R 3 3 v. 1 HR = 3.32c Yes Ss with LT mental
disorder at T1 excl.
Kendler 2010 Pop. 7733 Mix >18 2.5 Dx Past yr EPQ-S 12 v. Ctr. OR = 1.56a 0.27 No
Sen 2010 Pop. 740 54 26–30 (72%) 1 Sx Past 2 wk NEO-FFI 12 Cont. r = 0.115a 0.24 Yes Adj. for Sxdepression atT1.
Sx Past 2 wk Cont. β = 0.24a 0.60 Yes Adj. for Sx depression at
T1, personal history of
depression, difﬁcult
early rearing
environment
Vink 2009 CC 1712 49 55–85 9 Dx Past mo. DPQ 50 v. Ctr. OR = 1.58a 0.28 Yes Ss with Dx depression/
anxiety at T1 are excl.
Dx Past mo. v. Ctr. OR = 1.36a 0.19 Yes Ss with Dx depression/
anxiety at T1 are excl.,
Adj. for Sx anxiety/
depression at T1
Weiss 2009 CC 512 76 65–100, M = 79 (7) 1.8 Dx MD, past mo. NEO-FFI 2 v. Ctr. M (S.D.) 0.94 Yes Ss with major/minor
depression at T1 excl.
Dx Minor,
past mo.
v. Ctr. M (S.D.) 0.49 Yes Ss with major/minor
depression at T1 excl.
Dx MD, past mo. T Cont. OR = 2.28 0.50 Yes Ss with major/minor
depression at T1 excl.
Dx Minor, past mo. Cont. OR = 0.50 0.27 Yes Ss with major/minor
depression at T1 excl.
Duberstein 2008 Pop. 275 55 M = 70 15 Dx Past 15 yr MPI 48 Cont. HR = 1.05a^10.1 Yes Ss with Sx or history of
mental Dx excl. at T1
Dx Past 15 yr Cont. HR = 1.06a^10.1 Yes Ss with Sx or history of
mental Dx excl. at T1,
and adj. for incident
dementia 4T2 (n = 51)
Beard 2007 Pop. 968 57 18–85 1 Dx Past yr EPQ 24 v. Ctr. OR = 1.27 0.16 Yes Ss with any mental Dx
(ICD-10) at T1 excl.
Chien 2007 Pop. 1348 63 18–25, M = 20 (1) 1 Sx Past wk FFI 48 Cont. r = 0.49c 1.12 No
Fanous 2007 Twins 3030 0 20–58, M = 37 (9) 1.6 Dx Past yr EPQ 12 Cont. RR = 3.01a 0.81 No
Dx Past yr Cont. RR = 1.85a 0.43 Yes Ss with episodes of MD
prior to or at T1 excl.
Mofﬁtt 2007 Pop. 945 48 M = 18 14 Dx MD, past mo. MPQ NE Z v. Ctr. t = 6.18a 0.65 Yes Adj. for childhoodmental
disorders Dx.
Kendler 2006 Twins 20 692 Mix 14–77, M = 29 (9) 25 Dx 1st onset MD,
past LT
EPI 9 v. Ctr. X21 = 199.5
a 0.21 Yes Ss with a history of MD at
T1 excl.
Dx 1st onset MD,
past LT
v. Ctr. HR = 1.31a Yes Ss with a history of MD at
T1 excl.
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Table 1 (cont.)
First-named
author
Pub.
year Sample Size
C
(%)
Age (range and
mean (S.D.) at T1) T1/T2 (yr) Outcome variable N scale Cat. Comp.
Effect sizes
study outcome d’s
Adjustment for baseline (T1)
psychopathology
Dx 1st/rec. MD
past LT
v. Ctr. OR = 1.49a 0.24 Yes Ss with a history of MD at
T1 excl.
Kendler 2006 Twins 2935 0 M =∼33 (9) 4 Dx Past yr EPI 5 v. Ctr. SPRC = 0.20a 0.51 Yes Adj. for e.g. CD, early
onset anxiety
De Beurs 2005 Pop. 1837 56 55–85,M = 71 (8) 6 Sx Past wk DPI 30 Cont. β = 0.09a 0.28 No
De Graaf 2004 Pop. 2869 53 M = 42 (12) 3 Dx Mood, past 3 yr GNS 14 v. Ctr. OR = 1.18a 0.10 Yes Ss with history of mental
Dx excl. at T1
Kendler 2004 Twins 7517 Mix 13–58 9 Dx MD, past yr EPI 21 Cont. X21 = 109.7
a 0.24 No
Kendler 2004 Twins 1404 100 17–55, M = 30 (8) 2 Dx Past yr EPQ-S Z Cont. HR = 1.37 No
Neeleman 2004 Pop. 3625 53 18–65, M = 42 (12) 3 Dx Mood, past 2 yr EPI 28 Cont. OR = 2.22 0.48 No
Ormel 2004 CC 4796 Mix 18–64 3 Dx 1st MD, past yr ABI 14 Cont. d = 0.83a 0.83 No
Goodwin 2003 Pop./CC 961 50 M = 14 7 Dx Past 3 yr EPI 2 (3) 2 v. 1 Rates (%)ng 0.41 No
Tokuyama 2003 Pop. 1605 53 20–73 1 Dx Past 2 wk NEO-FFI 12 Cont. OR = 3.59a 0.77 Yes Adj. for past history of
MD and Dx at T1
De Graaf 2002 Pop. 5618 50 18–64 1 Dx Past yr GNS 2 (4) 2 v. 1 OR = 2.45d 0.54 No
Dx Past yr 2 v. 1 OR = 2.18d 0.47 Yes Adj. for Sx anxiety and
substance abuse at T1
Kendler 2002 Twins 1942 100 M = 29 (8) 7 (1) Dx MD, past yr EPQ-R 5 Cont. r = 0.39ng 0.85 No
Dx MD, past yr Cont. SPRC = 0.16 0.42 Yes Adj. for substance abuse
and Sx depr/anxiety
Wetherell 2001 Twins 1031 57 29–95, M = 61 (13) 6 Sx Past wk STPI-trait 50 Cont. r = 0.49ng 1.11 No
Fergusson 2000 CC 965 50 M = 14 7 Sx Suicidal id.,
past 6 yr
EPI 2 v. Ctr. Rates (%) 0.56 No
Sx Suicide att.,
past 6 yr
v. Ctr. Rates (%) 0.76 No
Sx Suicidal id.,
past 6 yr
12 Cont. PHRC = 0.09a No
Sx Suicidal id.,
past 6 yr
Cont. PHRC = 0.08a Yes Adj. Sx depression,
anxiety, CD, substance
use
Sx Suicide att.,
past 6 y.
Cont. PHRC = 0.06d No
Sx Suicide att.,
past 6 yr
Cont. PHRC = ns Yes Adj. Sx depression,
anxiety, CD, substance
use
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Krueger 1999 Pop./CC 961 50 M = 18 3 Dx Past yr MPQ NE Z Cont. OR = 1.27d 0.14 Yes Affective disorder Sx
at T1
Sx Past yr Cont. β = 0.12 0.34 Yes Affective disorder Sx
at T1
Gershuny 1998 Pop. 466 53 M = 18 (1) 3 Sx Past wk EPQ 23 Cont. r = 0.26a 0.54 No
Sx Past wk Cont. β = 0.08ns 0.27 Yes Adj. for Sx depression
at T1
Henderson 1997 Pop. 709 52 73–102, M = 80 (5) 4 Sx Past 2 wk EPQ-R 24 Cont. β = 0.08d 0.25 Yes Adj. for Sx depression
at T1
Caspi 1996 CC 1037 48 M = 3 18 Sx Past yr BRIC 2 (2) 2 v. 1 OR = 2.2c 0.48 No
Dx Suicide att. past yr 2 v. 1 OR = 6.5d 1.13 No
Krueger 1996 Pop. 897 48 M = 18 3 Sx Past yr MPQ NE 49 Cont. r = 0.24c 0.49 No
Clayton 1994 Pop. 2894 0 19 17 Dx Unipolar Dep. FPI 9 v. Ctr. Wa 0.59 Yes Ss with depression at
baseline were excl.
Kendler 1993 Twins 1733 100 17–55, M = 30 (8) 1.25 Dx MD, LT 12 S.D. b = 1.46a 0.23 No
Dx MD, past yr S.D. b = 2.40a 0.53 No
Dx MD, past yr S.D. b = 2.33a 0.51 Yes Ss with previous MD
episode at T1 excl.
Fergusson 1989 Pop. 1052 100 20–45 1 Sx Past yr EPI 24 Cont. r = 0.44ng 0.98 No
Levenson 1988 Pop. 1324 0 40–98 10 Sx Past 3 mo. EPI 9 Cont. r = 0.39a 0.85 No
Horwood 1986 Pop. 1027 100 20–45 1 Sx Past yr EPI 24 Cont. r = 0.54ng 1.28 No
Substance abuse (Including alcohol, illicit drugs, and tobacco)
Hakulinen 2015a Pop. 46 160 54 15–104, M = 50 5.5 Sx Alcohol,
past 5.5 yr
(9) 15 S.D. OR = 1.07a 0.02 No
Hakulinen 2015c Pop. 52 684 46 15–104, M = 51 5.5 Sx Smoking initiation (9) 20 S.D. OR = 1.02ns 0.00 No
Smoking relapse OR = 1.16 0.04 No
Newton-Howes 2015 Pop. 903 Nsc. 14 10 (10) Dx Alcohol dep. EPI 30 S.D. OR = 1.07ns 0.02 No
OR = 1.02ns 0.01 Yes Adj. for childhoodmental
health Sx and sexual/
physical abuse, among
others
Dx Illicit drug dep. OR = 1.04ns 0.01 No
OR = 1.05ns 0.01 Yes Adj. for childhoodmental
health problems and
sexual/physical abuse,
among others
Lee 2015 Pop. 465 47 M = 21 (0.9) 4 Sx Problem drinking
Alcohol
NEO-FFI 60 Cont. No effect 0.00 Yes Adjusted for problem
drinking at all waves
8 0.00 Yes Adjusted for problem
drinking at all waves
13 0.00 Yes Adjusted for problem
drinking at all waves
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Table 1 (cont.)
First-named
author
Pub.
year Sample Size
C
(%)
Age (range and
mean (S.D.) at T1) T1/T2 (yr) Outcome variable N scale Cat. Comp.
Effect sizes
study outcome d’s
Adjustment for baseline (T1)
psychopathology
Zvolensky 2015 Pop. 2101 Nsc 9 Sx Smoking MIDI 16 Cont. OR = 1.3a^S.D. 0.05 No
OR = 1.1a^S.D. 0.02 Yes Adj. for depression at T1
OR = 1.2a^S.D. 0.03 Yes Adj. for anxiety at T1
OR = 1.2a^S.D. 0.03 Yes Adj. for alcohol or drug
use problem at T1
Munafo 2007 Pop. 3562 Nsc M = 16 37 Sx Smoking MPI 12 6 cat. OR = 1.07a 0.02 No
Sx Heavy smoker OR = 1.14d 0.03 No
Schmidt 2007 Pop.14 404 61 M = 19 (4) 2 Dx Alcohol, past 2 yr STPI-Trait 60 Cont. r =−0.01ns −0.02 Yes Ss with psychiatric Sx/Dx
past 12 mo. excl. at T1
Grekin 2006 Pop. 3720 54 M = 18 2 Sx Alc., past 3 mo. NEO-FFI 60 Cont. r = 0.07c 0.14 No
Sx Drug, past 3 mo. Cont. r = 0.06c 0.12 No
Sx Tobacco, past yr Cont. r = 0.12c 0.24 No
Kendler 2006 Twins 2935 0 M =∼33 (9) 4 Dx Past yr EPI 5 Cont. SPRCns. 0.00 Yes Adj. for e.g. CD, early
onset anxiety
De Graaf 2004 Pop. 2869 53 M = 42 (12) 3 Dx Past 3 yr GNS 14 v. Ctr. OR = 1.09d 0.05 Yes Adj. for Ss with history of
mental disorders
excl. at T1
Neeleman 2004 Pop. 3625 53 18–65, M = 42 (12) 3 Dx Past 2 yr EPI 28 Cont. OR = 1.6 0.28 No
Goodwin 2003 Pop./CC 961 50 M = 14 7 Dx Past 3 yr EPI 2 (3) 2 v. 1 Rates (%)ng 0.07 No
De Graaf 2002 Pop. 5618 50 18–64 1 Dx Past yr GNS 2 (4) 2 v. 1 OR = 1.40d 0.20 No
Dx Past yr 2 v. 1 OR = 1.38ns 0.20 Yes Adj. for Sx mood and
anxiety at T1
Sher 2000 Pop. 457 50 M = 18 1 Dx Any substance
abuse, past yr
EPQ 30 r = 0.24a 0.55 No
7 r = 0.17d 0.35 No
1 Dx Alcohol abuse,
past yr
r = 0.22a 0.45 No
7 r = 0.13d 0.26 No
1 Dx Alcohol
dependent,
past yr
r = 0.17a 0.35 No
7 r = 0.12d 0.24 No
1 Dx Other drugs,
past yr
r = 0.16a 0.32 No
7 r = 0.10d 0.20 No
1 Dx Tobacco
dependent,
past yr
r = 0.15a 0.31 No
7 r = 0.14d 0.28 No
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Krueger 1999 Pop./CC 961 50 M = 18 3 Dx Past yr MPQ NE Z Cont. OR = 1.58c 0.28 Yes Adj. for Sx Substance
dependence disorder at
T1
Sx Past yr Cont. β = 0.09 0.28 Yes Adj. for Sx Substance
dependence disorder at
T1
Heath 1997 Twins 4974 63 27–90, M = 44 10 Dx Alcohol C, LT EPQ 2 (6) 2 v. 1 OR = 1.55d 0.27 Yes Adj. for LT Dx axis 1 at T1
Dx Alcohol F, LT 2 v. 1 OR = 1.87d 0.38 Yes Adj. for LT Dx axis 1 at T1
Caspi 1996 CC 1037 48 M = 3 18 Sx Alcohol, past yr BRIC 2 (2) v. Ctr. OR = 1.8ns 0.36 No
Krueger 1996 Pop. 897 48 M = 18 3 Sx Past yr MPQ NE 49 Cont. r = 0.36c 0.77 No
Thought disorders (Including psychosis, bipolar disorder, and schizophrenia)
Bogren 2010 Pop. 3215 49 Md = 33 40 Dx Psychosis
(non-affective and
affective)
(7) 52 Cont. HR = 2.84a No Adj. for age and sex
HR = 2.38c Yes Adj. for T1
paranoid-schizotypal
and tired-distracted Sx
2503 48 Md = 34 50 Dx (7) 52 Cont. HR = 2.27
c No Adj. for age and sex
HR = 2.31c Yes Adj. for T1
paranoid-schizotypal
and tired-distracted Sx
Lönnqvist 2009 Pop. 213
443
0 M = 20 (1.3) 14.1 Dx Schizophrenia, LT MMPI Nsc. Cont. OR = 1.40 0.09 No
OR = 1.26 0.06 No Adj. for intellectual
performance, age at
testing
Dx Bipolar, LT OR = 1.19 0.05 No
OR = 1.15 0.04 No Adj. for intellectual
performance, age at
testing
Dx Other psychoses OR = 1.32 0.07 No
OR = 1.19 0.05 No Adj. for intellectual
performance, age at
testing
Krabbendam 2005 Pop. 4848 Nsc 18–64 3 Sx Psychotic-like GNS 14 Cont. OR = 1.16a 0.04 No
Cont. OR = 1.20a 0.05 Yes Adj. for gender,
education, any
psychiatric Dx lifetime
3 v. 1 OR = 3.89a 0.36 No
Goodwin 2003 Pop./CC 961 50 M = 14 4 Sx Psychotic-like EPI 4 4 v. 1 IRR = 2.9a No
IRR = 1.8a Yes Adj. for childhood factors
and mental disorders
7 IRR = 2.4a No
IRR = 1.5a Yes Adj. for childhood factors
and mental disorders
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Table 1 (cont.)
First-named
author
Pub.
year Sample Size
C
(%)
Age (range and
mean (S.D.) at T1) T1/T2 (yr) Outcome variable N scale Cat. Comp.
Effect sizes
study outcome d’s
Adjustment for baseline (T1)
psychopathology
Krabbendam 2002 Pop. 3929 53 18–64, M = 42 (12) 3 Dx Psychosis (na.def.) GNS 28 Cont. OR = 1.20a 0.05 No
Psychosis (br.def.) OR = 1.16a 0.04 No
OR = 1.16a 0.04 Yes Adj. for T1 level of
anxiety and depression
and self-esteem
OR = 1.20a 0.05 Yes Adj. for T1 lifetime Dx,
marital and
employment status, age,
sex, education,
urbanicity, minority
status.
Van Os 2001 Pop. 5362 48 M = 16 27 Dx Schizophrenia MPI 12 Cont. OR = 1.93 0.17 No
OR = 1.83 0.16 Yes Adj. for PSE neurotic/
affective Sx, PSF Anx./
Dep. Sx at age 36 (after
20 years, but 16 years
before outcome).
OR = 1.41 0.09 No After adj. for selective
attrition for Neuroticism
and Ext.
Non-speciﬁc mental distress
Mezquita 2015 Pop. 241 66 18–29, M = 21 5 Sx Internalizing NEO-FFI 60 Cont. β = 0.58a 1.57 No2 Adj. for externalizing
spectrum at T2
Externalizing β = 0.00ns 0.00 No Adj. for internalizing
spectrum at T2
Johansson 2014 Pop. 800 Nsc. 38–54 6 Sx LT EPI 24 Cont. OR = 1.19 0.05 No
12 OR = 1.20 0.05 No
32 OR = 1.21 0.05 No
38 OR = 1.13 0.03 No
Beard 2007 Pop. 968 57 18–85 1 Dx Any Dx, past yr EPQ 24 v. Ctr. OR = 1.21a 0.12 Yes Ss with any mental Dx
(ICD-10) at T1 excl.
Neeleman 2004 Pop. 3625 53 18–65, M = 42 (12) 3 Dx Any psychiatric,
past 2 yr
EPI Z Cont. OR = 2.2a 0.48 No
Kuh 2002 Pop. 1086 100 M = 15 32 Sx Past yr MPI 12 Cont. β = 0.27a 0.66 Yes Adj. for adolescent
antisocial and anxious
Sx
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Tyssen 2001 Pop. 396 57 24–49, M = 28 (3) 3.6 Sx Past yr BCI-TV 9 Cont. OR = 1.3a 0.16 No
Sx Past yr OR = 1.0ns 0.00 Yes Adj. for previous mental
health problems
Wetherell 2001 Pop. 1031 57 29–95, M = 61 (13) 6 Sx Psych.som.
past wk
STPI-Trait 50 Cont. r = 0.42ng 1.01 No
Van Os 1999 Pop. 2415 50 M = 16 27 Sx Past yr MPI 12 Cont. β = 3.8c 2.07 Yes Adj. for mental health at
T1 and Ss with
schizophrenia were
excluded (n = 30)
Ormel 1991 Pop. 296 47 M = 39 (12) 7 Sx Psych.dis. past mo. ABV 8 Cont. r = 0.55d 1.32 No
ABI, Amsterdam Biographic Inventory; ABV, Amsterdam Biographic Questionnaire; Adj, adjusted; Anx, Anxiety; BCI-TV, Basic Character Inventory’s trait-vulnerability scale; BFI,
Big Five Inventory; BIS, behavioral inhibition system; br.def, broadly deﬁned; BRIC, Behavioral Ratings Inhibited child; cat., categories (i.e. range of the neuroticism scale, e.g. 4 items
with a 5-point likert scale is 20 categories); CC, case control; CD, conduct disorder; Comp., comparison (the number of neuroticism levels that were distinguished in the statistical test,
e.g. high v. low); Cont, continuous; Dep., Depression; DPI, Dutch Personality Inventory; DPQ, Dutch Personality Questionnaire; DS14, Type D-personality questionnaire; Dx, diagnosis;
EPI, Eysenck Personality Inventory; EPI-N, Neuroticism scale of the EPI; EPQ, Eysenck Personality Questionnaire; EPQ-R, Revised EPQ; ES, Emotional Stability; excl, excluded; Ext.,
Extraversion; FFI, Five Factor Inventory; FPI, Freiburg Personality Inventory; GNS, Groningen Neuroticism Scale; HR, hazard ratio; IR, interquartile range; IRR, incident rate ratio; LT,
life time; M, mean; Md, median; MD, major depression; mo., month; Mix, mixed; MPI, Maudsley Personality Inventory; MPQ, Multidimensional Personality Questionnaire; na, not
available; N, Neuroticism; na.def., narrowly deﬁned; NE, Negative Emotionality; NEO-FFI, NEO-Five Factor Inventory; Nsc, Nescio (I do not know); OR, odds ratio; PHRC,
proportional hazards regression coefﬁcients; Pop., population cohort; Psych.dis, psychological distress; Psych.som, psychological somatization; PSE, Present State Examination; PSF,
Psychiatric Symptom Frequency; PTSD, Post-traumatic stress disorder; r, correlation coefﬁcient; rec., recurrent; RR, relative risk; S.D., standard deviation; Soc.ph, social phobia; SPRC,
standardized partial regression coefﬁcients or path coefﬁcients; ss, subjects; STPI-Trait, State Trait Personality Inventory’s Trait-Anxiety measure; Suicidal id., suicidal ideation; Suicidal
att., suicidal attempt; Sx, symptoms; T, t score (mean=50, S.D.=10) or t test; v. Ctr, v. controls (without Dx); W, Wilcoxon test; wk, weeks; yr, year; Z, z score (mean=0, S.D.=1).
Notes: (1) Three waves of neuroticism form one latent variable thus the time-span between neuroticism and mental health reﬂects does not reﬂect the given follow-up time; (2) The
regression equation contained a dummy variable representing inhibited children (v. controls); (3) Neuroticism dichotomized at mean score; (4) Neuroticism dichotomized so that ⅓
received an unfavorable rating; (5) Neuroticism dichotomized at its median score [e.g. De Graaf et al. 2004, 55 with scale maximum of 15 (n= 800, or 58%)]; (6) Neuroticism
dichotomized above 75th percentile; (7) The Lundby ‘nervouse-tense’ cluster resulted from a mix of observable behaviors rated by psychiatrists (tense, restless, insecure, strained,
vegetative, lachrymose, see Hagnell, 1966) and structured questions (worried, nervous, tense, susceptible to adversity, cries easily, difﬁcult to collect one’s thought); (8) Two groups
were derived with latent growth analysis and growth mixture modeling, a moderate class (77%, mean intercept= 2.1) and a high class (23%, mean intercept= 2.8), see Aldinger et al.
(2014); (9) In these analyses ten studies were pooled, and each sample used different instruments, but with a minimum of 15 items each (Hakulinen et al. 2015a–c); (10) The outcomes
were measured at age 21, 25, and 30 years, or 4–16 years after baseline, and summarized, with 10 years follow-up as the mean span.
ap < 0.001, bp < 0.005, cp < 0.01, dp < 0.05, ns, non-signiﬁcant, ng, signiﬁcance not given.
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(extraversion/conscientiousness/agreeableness/openness),
and although reported in Table 1 (e.g. Hakulinen et al.
2015b), these estimates were excluded from the meta-
analytic estimates. Furthermore, our study included two
meta-analysis of prospective cohort studies of the associ-
ation between neuroticism and depressive symptoms
and substance abuse (Hakulinen et al. 2015a, b).
Measurement of personality
Neuroticism was assessed with a variety of standardized
questionnaire instruments, including the NEO Five-
Factor Inventory (12 items), the revised Eysenck
Personality Questionnaire (12 items), the Amsterdam
Biographic Interview (14 items), Basic Character
Inventory’s trait-vulnerability scale (9 items), the Dutch
Personality Inventory (15 items), Dutch Personality
Questionnaire (25 items), Groningen Neuroticism
Scales (14 items), Maudsley Personality Inventory (12
items), the Freiburg Personality Inventory (9 items),
and the State Trait Personality Inventory trait-anxiety
measure (10 items). These were all developed to measure
negative emotionality, neuroticism, emotional stability,
trait-anxiety, and/or trait-vulnerability.
Table 2. A summary of predictive effects of neuroticism as sample-size weighted effect-sizes d over K studies and N participants
Symptoms Diagnosis
Disorder K N d S.D.d K N d S.D.d
Anxiety Unadjusted 9 10 130 0.68 0.46 4 7748 0.48 0.57
Adjusted 6 6104 0.38 0.32 9 14 646 0.18 0.14
Depression Unadjusted 11 13 379 0.74 0.37 12 39 161 0.50 0.36
Adjusted 4 2 876 0.33 0.14 16 49 585 0.33 0.39
Substance abuse Unadjusted 7 110 161 0.03 0.02 5 11 564 0.20 0.24
Adjusted 3 3527 0.09 0.12 8 19 068 0.17 0.26
Thought disorders Unadjusted 1 4848 0.04 0.00 3 222 734 0.07 0.11
Adjusted 1 4848 0.05 0.00 2 9291 0.11 0.11
Non-speciﬁc mental distress Unadjusted 5 2764 0.69 0.74 1 3625 0.48 0.00
Adjusted 3 4804 0.27 0.24 1 968 0.12 0.00
K, Number of studies; N, pooled sample size; d, sample size-weighted average effect size; S.D.d, sample size-weighted
standard deviation of effect sizes. Details can be found in the Method section.
Table 3. A summary of the prospective associations between neuroticism and symptoms/diagnosis as sample-size weighted effect sizes d over K
studies and N participants, for short v. long time intervals
Symptoms Diagnosis
Years K N d S.D.d K N d S.D.d
Unadjusted 33 141 282 0.15 0.11 25 284 832 0.15 0.26
Short interval <4 13 18 684 0.47 0.32 12 49 407 0.42 0.28
Long interval 54 20 122 598 0.11 0.08 14 235 882 0.10 0.23
Adjusted 17 22 159 0.23 0.20 36 93 559 0.25 0.35
Short interval <4 13 15 185 0.25 0.21 22 49 140 0.24 0.30
Long interval 54 4 6974 0.20 0.21 14 44 419 0.27 0.39
K, Number of studies; N, pooled sample size; d, sample size-weighted average effect size; S.D.d, sample size-weighted
standard deviation of effect sizes. The division of studies over short interval (<4 years) and long interval (54 years) was
based on the median follow-up time, which was three years for dichotomous measures, four years for continuous measures,
and four years overall (i.e. across all 111 estimates). When studies reported estimates for both short and long intervals both
were included in the short v. long interval estimations, but only one was included in the summary estimates. Unadjusted
estimates are the direct associations between neuroticism and outcome. Adjusted estimates provide the prospective associations
adjusted for symptoms/diagnosis at baseline (see Method section).
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Prospective associations
The large S.D.s around the averages shown in Table 2,
indicate that the pool of studies is quite heterogeneous.
Nonetheless, the data clearly support the ability of
neuroticism to predict all symptoms and diagnoses
under study. The estimated unadjusted prospective
associations between neuroticism and symptom mea-
sures were comparable for anxiety, depression, and
non-speciﬁc mental distress, and all quite large
(about d = 0.70). When these estimates were adjusted
for baseline symptoms, the effect size reduced most
for non-speciﬁc mental distress (−60%), followed by
depression (−55%), and anxiety (−45%). The unadjust-
ed prospective associations between neuroticism and
diagnosis for anxiety or depressive disorder were
slightly lower (about d = 0.50), but the trends were
similar to the effects seen for symptom scores, as
well as the reduction of the association after adjust-
ment for baseline measures. Hence, regarding internal-
izing symptoms and diagnosed disorders, and
non-speciﬁc mental distress, unadjusted associations
were about twice the size of the adjusted effects, but
adjusted effects remained signiﬁcant.
The estimated unadjusted prospective association
between neuroticism and substance use symptoms
was considerably weaker (below d = 0.10), even though
estimates for diagnosis had a moderate effect size (d =
0.20). Notably, the latter effect became only little atte-
nuated after adjustment for baseline symptoms
(−15%). Although some adjusted estimates appear to
be larger than the unadjusted estimates, these differ-
ences were small (d40.04), and are probably insigniﬁ-
cant. In sum, adjusted effects were reduced by half for
internalizing problems, but not for substance abuse
and thought disorders.
Temporal stability
A summary of the prospective associations between
neuroticism and CMDs is presented in Table 3.
Categorization of the follow-up interval over short
and long intervals was based on the median study
length (short was 44 years, long was >4 years).
Overall the unadjusted prospective associations were
identical for studies of symptoms and diagnoses
(both d = 0.15). However, the unadjusted short-term as-
sociation was about four times larger than the long-
term association, for both symptoms and diagnoses.
This indicates a substantial decay of the association
with increasing time intervals.
The adjusted effects, on the other hand, were com-
parable for symptoms and diagnoses (both about
d = 0.25). The adjusted prospective associations for symp-
toms were only slightly larger over the short follow-up
interval than over the long follow-up interval, whileT
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for diagnosis the long-term estimate was even slightly
stronger than the short term effect (yet with d = 0.03
the difference was negligible). Note that all adjusted
effects were of moderate effect size, also the long-term
associations. So, after adjustment for concomitant pro-
blems at baseline and/or psychiatric history, there was
little difference between the short and long follow-up
interval. This result can be interpreted as concomitant
problems at baseline masking the long-term stability of
the neuroticism effect on the internalizing CMDs.
Disorder types
The scarcity of studies did not allow for a systematic
comparison of prospective associations between neur-
oticism and each disorder separately. However, the
studies given in Table 1 indicate that among the anx-
iety disorders, large prospective associations were
observed for panic disorder, GAD, social phobia, and
PTSD, respectively. For depressive disorders the pro-
spective associations were observed for major depres-
sive disorder, minor depressive disorder, and suicidal
ideation. Prospective associations between neuroticism
and substance use disorders, although small, were
observed for smoking and alcohol or illicit drug
abuse. Regarding the thought disorders, small pro-
spective associations were observed for schizophrenia
and psychosis, but no effect for bipolar disorders.
Post-hoc
The prospective association between neuroticism and
the onset of CMDs differs across disorders (e.g. intern-
alizing v. externalizing). Because so little data was
available for each speciﬁc disorder cluster we com-
bined all disorders when calculating the short-term v.
long-term effects, to focus on broad and general con-
clusions. Post-hoc we also calculated the standardized
drop in d values per year for each speciﬁc cluster, div-
iding the effect sizes by the number of years between
assessments, as reported in Table 4. This dimensional
reduction in d per follow-up year was rather small,
and largely comparable across the disorders, in sup-
port of neuroticism as a robust prospective marker
for the development of psychopathology.
Discussion
In this paper precise estimates are given of the predict-
ive power of neuroticism for the development of psy-
chopathology, as well as effects for individual
disorders. Three key observations were found. First,
the unadjusted prospective associations between neur-
oticism and internalizing symptom measures or diag-
nosis were quite large (d = 0.48 to 0.74, i.e. anxiety,
depression, non-speciﬁc distress). An adjustment of
these estimates for baseline symptoms reduced the
effect size by half, but the residual associations
remained substantial (d = 0.12–0.38). Second, the un-
adjusted prospective associations between neuroticism
and substance use symptoms and thought disorder
symptoms were considerably weaker (d = 0.03–0.20),
but importantly, adjustment for baseline problems
did not attenuate these effects (d = 0.05–0.17). Third,
the adjusted prospective associations between neuroti-
cism and psychopathology remained stable over long
follow-up intervals (on average d = 0.25, with little
decay per year), bolstering our understanding of neur-
oticism as an independent and robust vulnerability
marker for later developing psychopathology.
Over the past three decades theorists proposed a set of
theoretical models to explain the complex longitudinal
interrelations between personality and psychopathology
and toutilize their conceptual differences to infer hypoth-
eses aboutmechanisms that can account for their (co-)de-
velopment (e.g. Tackett, 2006;Ormel et al. 2013; Durbin&
Hicks, 2014).Thepresent studywasdesigned to test infer-
ences from the vulnerability model, which holds that
neuroticism sets in motion processes that lead to CMDs.
Next to the vulnerability and common cause models
(same processes), also the spectrum model (CMDs are
extreme levels of neuroticism) andpathoplasty/exacerba-
tion models (independent etiology and onset, but neur-
oticism inﬂuences the course, severity, presentation, or
prognosis of CMDs) can account for different aspects of
the prospective neuroticism-CMD association, or for dif-
ferent symptom clusters. Different people may even
achieve the same end (function) by different means
(mechanisms). Next we discuss implications of present
ﬁndings for each model.
Vulnerability perspective
The vulnerability model postulates that high neuroti-
cism causes the development of CMDs, either ‘direct-
ly’, or by eliciting other risk factors. Examples of
direct processes are the cognitive vulnerabilities that
are associated with neuroticism, including a pessim-
istic inferential style (negative attention bias and
information recall), rumination, increased reactivity
(psychological/physiological), ineffective coping/dys-
functional attitudes, intolerance of uncertainty/anx-
iety sensitivity, and fear of negative evaluation
(Chan et al. 2007; Servaas et al. 2013; Barlow et al.
2014; Hong & Cheung, 2014; Laceulle et al. 2015).
Examples of indirect vulnerabilities is high neuroticism
increasing exposure to stressful life events (Kendler et al.
2003; Jeronimus et al. 2014; Riese et al. 2014), and experi-
encing three times more interpersonal stressful events
(Fergusson & Horwood, 1987; Poulton & Andrews,
1992; van Os & Jones, 1999; Specht et al. 2011).
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In our test of the vulnerabilitymodelwe evaluated the
ability of neuroticism to predict the onset of a given dis-
order after adjusting for the symptoms present at base-
line and psychiatric history. This was done to adjust
(a) for state effects in neuroticism (Ormel et al. 2012;
Jeronimus et al. 2013), which are evidenced by our
results, and (b) scars that earlier episodes may have left
in terms of heightened neuroticism levels (Wichers
et al. 2010; Klein et al. 2011; Ormel et al. 2013). Our un-
adjusted estimate of the prospective association be-
tween neuroticism and internalizing disorders (d =
0.60) was substantially lower than the meta-analytic es-
timate of the cross-sectional association by Kotov et al.
(2010, d = 1.65). The cross-sectional estimate was
adjusted for unreliability of the included neuroticism
scales (as indexed by Cronbach’s α = 0.82), which
ampliﬁed this difference.
The current paper showed that half of the prospect-
ive association between neuroticism and internalizing
problems was due to relationships with mental state
(baseline problems and psychiatric history). These
state effects, in which neuroticism levels are temporar-
ily heightened by acute internalizing problems, are
temporary, and generally disappear after the episode
has remitted (Ormel et al. 2004, 2013; Jeronimus et al.
2013). A moderate but robust residual prospective as-
sociation with internalizing problems remained (d =
0.30 to 0.40), in line with the vulnerability model. But
not inconsistent with most other models, including
common causes, provided that personality develops
earlier than a disorder, even without any direct causal
connections. Importantly, this control for baseline pro-
blems is a conservative test that takes legitimate vari-
ance out of neuroticism, especially from the facet
traits anxiety and depression (Riese et al. 2016).
For substance abuse and thought disorders the dif-
ferences between the cross-sectional estimates by
Kotov et al. (d = 0.97) and our unadjusted prospective
associations (d = 0.20) were even slightly larger.
Because baseline problems and psychiatric history
did not attenuate the prospective association between
neuroticism and substance abuse and thought disor-
ders, neuroticism proves a robust vulnerability factor
for their development without much conceptual over-
lap. Note that the small effect sizes indicate that high
neuroticism only plays a modest role in their – un-
doubtedly multifactorial – etiology, or only for some
people.
All adjusted prospective associations between neur-
oticism and the CMDs were moderate in magnitude
andvirtually equivalent for the short and long follow-up
interval, which indicates that the risk effect of neuroti-
cism did not weaken over time, which is strong support
for the vulnerabilitymodel.Our results alignwith previ-
ously articulated differences between internalizing
(anxiety, depression, non-speciﬁc mental distress) and
externalizing spectra (substance abuse) of psychopath-
ology and thought disorders (Krueger et al. 1996;
Krueger & Tackett, 2003; Kotov et al. 2010), and indicate
that neuroticism is close to the origins of their causal
pathways, via vulnerability and common causes. These
observations support the argument that neuroticism
forms the core of a ‘general factor of psychopathology’
characterized by negative-emotional dysregulation (dis-
tress) and thought disorders (Lahey et al. 2011; Caspi
et al. 2013; Barlow et al. 2014; Kotov et al. 2015; Laceulle
et al. 2014; Pettersson et al. 2016).
Common causes
Although our results can be interpreted as evidence for
the vulnerability model, they do not falsify alternative
models, including the common cause model. The com-
mon cause model assumes that neuroticism and men-
tal disorder are dynamic phenomena that can change
together in response to external forces and develop-
mental pressures such that both become causally inter-
twined (Ormel et al. 2013; Durbin & Hicks, 2014). Only
mediation data can disentangle the vulnerability
model from common causes, and this was outside
the scope of our study. The common cause model is
supported by the substantial genetic overlap between
neuroticism and CMDs (e.g. Hettema et al. 2006), al-
though this does not falsify the spectrum model.
Spectrum perspective
The spectrum perspective holds that neuroticism
shades continuously into manifestations of psycho-
pathology at the high end of the distribution, and
both share their etiological core (e.g. Krueger &
Tackett, 2003; Ormel et al. 2013). Importantly, the spec-
trum model eliminates all conceptual distinctions be-
tween neuroticism and CMDs as they tap into the
same construct. It follows that (a) the correlation be-
tween the measures should approach the reliabilities
of the measures and (b) the measures should show
comparable patterns of external correlates (Durbin &
Hicks, 2014); which does not hold for neuroticism
(Ormel et al. 2013). Moreover, the spectrum model im-
plies that psychopathology is simply a label given to
extreme scores on a trait, and thus no cases of a dis-
order will be found below the threshold while all peo-
ple above the threshold will be cases. The evidence that
most people with high neuroticism scores do not ex-
perience psychopathology, whereas some people
with low neuroticism scores do, contradicts this impli-
cation. Further difﬁculty for the spectrum account is
that scoring high on neuroticism prospectively predicts
lower romantic and occupational success, subjective
wellbeing, longevity, and higher frequency of mental
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and general health service use (Hills & Argyle, 2001;
Ozer & Benet-Martínez, 2006; Roberts et al. 2007;
Steel et al. 2008; Lahey, 2009), among others. The spec-
trum model cannot account for individual differences
in personal resources and contextual factors that may
result in the eventual non-expression of mental health
problems (Duckworth et al. 2005; van der Krieke et al.
2015), or the natural course and dynamics of personal-
ity development – among which a normative decrease
in neuroticism of d = 0.77 towards middle age (see
Roberts et al. 2006), nor the bidirectional relationships
between neuroticism and symptoms (Ormel et al.
2013, 2014).
Co-development model
Recent reviews of etiological models of personality-
psychopathology associations concluded that (a) the
vulnerability, common-cause, and spectrum models
are imprecise, which impedes the formulation of critic-
al tests to distinguish them, (b) the processes are not
mutually exclusive and could co-occur within the
same individual or be more relevant for some people
than others (Tackett et al. 2006; Ormel et al. 2013;
Durbin & Hicks, 2014), and (c) the models lack a dy-
namic lifespan perspective in which psychopathology
can be conceived of as deviation from normative devel-
opmental trends (see Cicchetti, 1993). Additionally,
processes that link traits and disorders may also vary
across developmental periods (Tackett, 2006; Durbin
& Hicks, 2014), if only due to different developmental
tasks, goals, needs, relationships, developmental con-
texts, and lifespan personality development (e.g.
Roberts et al. 2006; John et al. 2008).
Durbin & Hicks (2014) therefore proposed a
personality-psychopathology co-development model
that incorporates the vulnerability, common causes,
pathoplasticity, and exacerbation mechanisms, and
accounts for lifespan personality development and dy-
namic processes via which high neuroticism shapes the
ways in which people structure and interact with the
world around them to explain individual differences
in life experiences and transitions and their impact
(e.g. Kendler et al. 2003; Jeronimus et al. 2014). In line
with the co-development perspective the adjusted pro-
spective association between high neuroticism and in-
ternalizing problems can be interpreted as an
independent vulnerability effect for the development
of psychopathology (neuroticism→Sx/Dx) while the
overlap at baseline may reﬂect state effects, common
causes, or symptoms intervening between neuroticism
and diagnosis (neuroticism→Sx→Dx). Recall that our
adjusted estimate, controlling for baseline symptoms,
also removes true predictive variance from neuroticism.
Finally, a transition to and from a psychiatric disorder
may proceed as a categorical sudden transition for
some people but in terms of a smooth process of change
in others (Borsboom et al. 2016). Nonetheless, a salient
difference between the co-development and spectrum
models remains that the former retains conceptual dis-
tinctions between neuroticism and disorder.
Future studies
Our understanding of the etiology of psychopathology
and early detection and intervention of CMD is unlike-
ly to expand via additional studies of cross-sectional
neuroticism–CMD correlations. To further clarify dif-
ferent perspectives we need a deeper understanding
of the boundaries between neuroticism and psycho-
pathology, such as function v. dysfunction (DSM-5),
or trait descriptors as self-identity in semantic memory
and mental symptoms as episodic memories (Ormel
et al. 2014). Also questionnaires without item overlap
are needed (Ormel et al. 2013). And the inclusion of po-
tential common causes and external correlates of neur-
oticism and CMDs in longitudinal designs.
At least as important may be the study of individ-
ual differences in their individual developmental con-
text and developmentally informed mechanisms
underlying the independent prospective association
between neuroticism and CMDs. For example, medi-
ation of the vulnerability effect by cognitive biases in-
herent to neuroticism (e.g. Laceulle et al. 2015), or
moderation of effects by contextual and sociodemo-
graphic factors, ethnicity, or other personality traits.
Evidence suggests that CMDs share a pleiotropic gen-
etic susceptibility that is manifest via dysfunction in
neurobiological systems, while different interactions
with one’s environment somehow differentiate be-
tween speciﬁc disorder outcomes (e.g. Lahey et al.
2011). This underscores the need for research
designs that can account for both inter-individual and
intra-individual variance, such as experience sampling,
which may help answer questions about processes
that underlie the neuroticism-psychopathology link
(Molenaar, 2008; van der Krieke et al. 2015).
Finally, studies could improve by accounting for
more hierarchical aspects of the personality and psy-
chopathology, which may also increase our under-
standing of causal processes. Neuroticism comprises
multiple lower-order facet traits, including anxiety, de-
pression, angry-hostility, self-consciousness, impul-
siveness and vulnerability (Costa & McCrae, 2006).
The facets of neuroticism differ in their underlying
biology, developmental trends, impact on impairment,
and risk factors (Jeronimus, 2015). But also speciﬁc
CMD symptoms including sadness, insomnia, concen-
tration problems, or suicidal ideation, associate with
differences in external outcomes, including social
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relationships, work, and subjective wellbeing (e.g.
Fried et al. 2014; Fried & Nesse, 2015). Research at
this level of granularity may therefore also advance
the development of personalized prevention and treat-
ment strategies (Borsboom & Cramer, 2013; van der
Krieke et al. 2015), which can impact both high neuroti-
cism and CMD episodes (Barlow & Nock, 2009; Lahey,
2009; Ormel et al. 2013).
Implications
Our results clearly show independent prospective
associations between high neuroticism and manifesta-
tions of psychopathology and mental distress. Extant
work indicated that neuroticism levels are more malle-
able than researchers long believed, including the po-
tential of a benign transactional cycle between
positive contextual changes and decreases in neuroti-
cism (Lüdtke et al. 2011; Kuepper et al. 2012;
Jeronimus et al. 2013, 2014). Multiple studies showed
the feasibility of ‘treating’ high neuroticism or speciﬁc
neuroticism facets (Jorm, 1989; Zinbarg et al. 2008;
Glinski & Page, 2010; Martin et al. 2014; Hudson &
Fraley, 2015), both via psychological and pharmaco-
logical interventions (d = 0.40–1.25). Therapists could
thus focus on prevention strategies that target the vul-
nerability for mental disorders inherent in neuroticism,
rather than only treating the subsequent manifestations
of those disorders (Lahey, 2009; Cuijpers et al. 2010;
Ormel et al. 2013; Barlow et al. 2014). This could be
implemented as aftercare of psychological counseling.
From a dynamic system perspective the most promis-
ing and rigorous measure to improve future mental
health might be to target the developing personality
structure from primary school age onwards to
smoothen the mental biases and developing belief sys-
tems that otherwise could develop into high neuroti-
cism throughout adolescence, to alleviate the
observed vulnerability for the co-development of men-
tal disorders associated with high neuroticism.
Limitations
The present work extends earlier work on neuroticism-
psychopathology associations to a critical evaluation of
the prospective associations to shed light on the vulner-
ability hypothesis of psychopathology.Other broadper-
sonality traits have often been linked to CMDs as well,
namely, low Conscientiousness, and to a lesser extent,
Extraversion, although their association with CMDs is
not as strong and pervasive as that of neuroticism (e.g.
Clark, 2005; Khan et al. 2005; Malouff et al. 2005;
Fanous et al. 2007; Kotov et al. 2010; Klein et al. 2011;
Hakulinen et al. 2015a, b, c). Analyses of these traits are
outside the scope of this meta-analysis, but we believe
that the implications of our ﬁndings on neuroticism
are relevant for understanding the relationship between
other personality traits and CMDs as well. In this
meta-analysis studies that adjusted their neuroticism
effects for the other personality traits were excluded.
Our aim was to control for baseline symptoms and
psychiatric history to establish the likely direction of
causality, and adjustment for other traits does not help
with that, while it changes the nature of the effect (i.e.
it is not whole neuroticism that now predicts).
Nonetheless, studies that included all traits supported
the primacy of neuroticism (e.g. Hakulinen et al.
2015a–c). Finally, in this paper studies with widely dif-
ferent instruments were compared, and as in previous
comparisons, these instruments yield different effects.
For example, neuroticism as measured by instruments
derived from Eysenck’s tripartite taxonomy (MPI, EPI,
EPQ, EPQ-R) appeared less predictive for psychopath-
ology than the NEO scales (cf. Kotov et al. 2010).
In some categories in Table 3 the S.D. is larger than the
mean, which reﬂects the substantial variability between
the estimates. Arguably this is due to the different study
groups, from different countries, administered with dif-
ferent instruments and methods. Although large S.D.s
may suggest unprecise estimations (due to dispersion),
this does not imply that the mean point estimate is
not a good parameter. Furthermore, neuroticism’s asso-
ciations with symptom measures based on self-ratings
are typically stronger than for diagnoses (Table 2).
Diagnoses are typically based on diagnostic interviews.
These differences were largest for the internalizing pro-
blems (i.e. anxiety, depression, and non-speciﬁc mental
distress), but reversed for substance abuse and thought
disorders. This suggests the existence of method vari-
ance, as both neuroticism and symptom measures are
typically assessed with self-ratings, whereas diagnostic
interviews are based on self-report in response to inter-
viewer questions. Unfortunately, our estimation method
impedes an estimate of method variance in the observed
prospective associations with diagnoses. Note that in
our overall effect estimates, these differences between
symptoms and diagnoses disappeared (Table 3).
Conclusion
Our results indicate that high neuroticism and psycho-
pathology are not only closely interwoven but that
neuroticism is also an important prospective indicator
of risk for the development of psychological disorders
in the internalizing domain, especially anxiety, depres-
sion, and non-speciﬁc mental distress. Neuroticism is
also a vulnerability factor for the development of sub-
stance abuse and thought disorders, although these
effects are much weaker. Half of the prospective effect
remained after adjustment for baseline psychopath-
ology and psychiatric history. Particularly relevant is
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the long-term stability of the residual vulnerability ef-
fect of high neuroticism. Whereas the unadjusted
short-term effect estimates were four times larger
than the long-term effects (suggesting a substantial
decay of the association with increasing time intervals),
the adjusted short-term effect was only slightly larger
than the long-term effect. Collectively, our results iden-
tify high neuroticism as a stable and signiﬁcant vulner-
ability factor for the development of CMDs.
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